Pinnacle Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Pinnacle Associates’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,165	Closed	-$253K	–	784
2021 Q1	$253K	Buy	+1,165	New	+$219K	﹤0.01%	661
2020 Q3	–	Sell	-2,165	Closed	-$266K	–	707
2020 Q2	$266K	Buy	+2,165	New	+$246K	0.01%	582
2019 Q4	–	Sell	-2,066	Closed	-$238K	–	746
2019 Q3	$238K	Buy	2,066 +720	+53%	+$109K	0.01%	641
2019 Q2	$232K	Sell	1,346 -204	-13%	-$35.3K	0.01%	639
2019 Q1	$261K	Buy	+1,550	New	+$231K	0.01%	622
2018 Q4	–	Sell	-1,525	Closed	-$263K	–	729
2018 Q3	$263K	Buy	+1,525	New	+$220K	0.01%	629

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Pinnacle Associates's GWPH Position: Q2 2021 in Review

Pinnacle Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,165 shares — an estimated $253K sold.

Pinnacle Associates first reported a position in GWPH in Q3 2018 and held it in 6 quarters. The position peaked at $266K in Q2 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Pinnacle Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Pinnacle Associates sold 1,165 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $253K.
Pinnacle Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 6 quarters.
Pinnacle Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $266K in Q2 2020.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Pinnacle Associates's 13F filing for Q2 2021, filed 2 Aug 2021.